GSK Makes ADC Pipeline Comeback With Mersana Deal

Pays $100m Upfront

 
• By Ayisha Sharma
Purple Cells
GSK Already Has One ADC Product On The Market For Multiple Myeloma • Source: Shutterstock

More from Business

More from Scrip